Wall Street Journal reports on Tauler Smith’s battle against SARMs

A Sacramento sports supplement company faces litigation from Tauler Smith LLP for selling consumers Selective Androgen Receptor Modulators (SARMS), a class of experimental steroid-like drugs not approved for human consumption. Wall Street Journal legal reporter Jacob Gershman wrote that Robert Tauler is a “sheriff of the performance-enhancing supplement industry, going after vendors for falsely marketing SARMS as safe and natural, when they in fact are much more dangerous than advertised.
Read the story here (subscription may be required): https://tinyurl.com/WSJSarms